{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T04:34:27Z","timestamp":1771475667499,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,4,13]],"date-time":"2010-04-13T00:00:00Z","timestamp":1271116800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s12022-010-9118-7","type":"journal-article","created":{"date-parts":[[2010,4,12]],"date-time":"2010-04-12T10:42:52Z","timestamp":1271068972000},"page":"108-114","source":"Crossref","is-referenced-by-count":27,"title":["Anti-Saccharomyces cerevisiae Antibodies are Frequent in Type 1 Diabetes"],"prefix":"10.1007","volume":"21","author":[{"given":"Wahiba","family":"Sakly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amani","family":"Manka\u00ef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil","family":"Sakly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosra","family":"Thabet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achouak","family":"Achour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Ghedira-Besbes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moncef","family":"Jeddi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibtissem","family":"Ghedira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,13]]},"reference":[{"key":"9118_CR1","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.autrev.2008.04.008","volume":"7","author":"M Knip","year":"2008","unstructured":"Knip M, Siljander H. Autoimmune mechanisms in type 1 diabetes. Autoimmun Rev 7:550-7, 2008.","journal-title":"Autoimmun Rev"},{"key":"9118_CR2","doi-asserted-by":"crossref","unstructured":"Knip M, Veijola R, Virtanen SM, Hy\u00f6ty H, Vaarala O, Akerblom HK. Environmental triggers and determinants of type 1 diabetes. Diabetes 54(Suppl 2):125-36, 2005.","DOI":"10.2337\/diabetes.54.suppl_2.S125"},{"key":"9118_CR3","first-page":"162","volume":"56","author":"A Mokrowiecka","year":"2009","unstructured":"Mokrowiecka A, Daniel P, S\u0142omka M, Majak P, Malecka-Panas E. Clinical utility of serological markers in inflammatory bowel disease. Hepatogastroenterology 56:162-6, 2009.","journal-title":"Hepatogastroenterology"},{"key":"9118_CR4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s10875-008-9255-7","volume":"29","author":"S Ashorn","year":"2009","unstructured":"Ashorn S, V\u00e4lineva T, Kaukinen K, Ashorn M, Braun J, Raukola H, et al. Serological responses to microbial antigens in celiac disease patients during a gluten-free diet. J Clin Immunol 29:190-5, 2009.","journal-title":"J Clin Immunol"},{"key":"9118_CR5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/00365520601154996","volume":"42","author":"D Toumi","year":"2007","unstructured":"Toumi D, Manka\u00ef A, Belhadj R, Ghedira-Besbes L, Jeddi M, Ghedira I. Anti-Saccharomyces cerevisiae antibodies in coeliac disease. Scand J Gastroenterol 42:821-6, 2007.","journal-title":"Scand J Gastroenterol"},{"key":"9118_CR6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00042737-200601000-00013","volume":"18","author":"RCh Mallant-Hent","year":"2006","unstructured":"Mallant-Hent RCH, Mary B, von Blomberg E, Yuksel Z, Wahab PJ, Gundy C, et al. Disappearance of anti-Saccharomyces cerevisiae antibodies in coeliac disease during a gluten-free diet. Eur J Gastroenterol Hepatol 18:75-8, 2006.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"9118_CR7","first-page":"37","volume":"55","author":"S Fagoonee","year":"2009","unstructured":"Fagoonee S, De Luca L, De Angelis C, Castelli A, Rizzetto M, Pellicano R. Anti-Saccharomyces cerevisiae as unusual antibodies in autoimmune hepatitis. Minerva Gastroenterol Dietol 55:37-40, 2009.","journal-title":"Minerva Gastroenterol Dietol"},{"key":"9118_CR8","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s10620-007-0092-y","volume":"53","author":"W Sakly","year":"2008","unstructured":"Sakly W, Jeddi M, Ghedira I. Anti-Saccharomyces cerevisiae antibodies in primary biliary cirrhosis. Dig Dis Sci 53:1983-7, 2008.","journal-title":"Dig Dis Sci"},{"issue":"4 Suppl 26","key":"9118_CR9","first-page":"S21","volume":"20","author":"I Krause","year":"2002","unstructured":"Krause I, Monselise Y, Milo G, Weinberger A. Anti-Saccharomyces cerevisiae antibodies a novel serologic marker for Behcet\u2019s disease. Clin Exp Rheumatol 20(4 Suppl 26):S21-4, 2002.","journal-title":"Clin Exp Rheumatol"},{"key":"9118_CR10","unstructured":"Aydin SZ, Atagunduz P, Temel M, Bicakcigil M, Tasan D, Direskeneli H. Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthropathies: a reassessment. Rheumatology (Oxford) 47:142-4, 2008."},{"key":"9118_CR11","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1177\/0961203309105131","volume":"18","author":"H Dai","year":"2009","unstructured":"Dai H, Li Z, Zhang Y, Lv P, Gao XM. Elevated levels of serum antibodies against Saccharomyces cerevisiae mannan in patients with systemic lupus erythematosus. Lupus 18:1087-90, 2009.","journal-title":"Lupus"},{"key":"9118_CR12","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/j.1365-2036.2006.02916.x","volume":"23","author":"R D\u2019Inca","year":"2006","unstructured":"D\u2019Inca R, Annese V, di Leo V, Latiano A, Quaino V, Abazia C, et al. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn\u2019s disease. Aliment Pharmacol Ther 23:1455-61, 2006.","journal-title":"Aliment Pharmacol Ther"},{"key":"9118_CR13","doi-asserted-by":"crossref","unstructured":"Duerksen DR, Wilhelm-Boyles C, Veitch R, Kryszak D, Parry DM. A comparison of antibody testing, permeability testing, and zonulin levels with small-bowel biopsy in celiac disease patients on a gluten-free diet. Dig Dis Sci 55:1026-31, 2009.","DOI":"10.1007\/s10620-009-0813-5"},{"key":"9118_CR14","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s10620-006-9544-z","volume":"51","author":"JJ Feld","year":"2006","unstructured":"Feld JJ, Meddings J, Heathcote EJ. Abnormal intestinal permeability in primary biliary cirrhosis. Dig Dis Sci 51:1607-13, 2006.","journal-title":"Dig Dis Sci"},{"key":"9118_CR15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/ard.60.1.65","volume":"60","author":"I Fresko","year":"2001","unstructured":"Fresko I, Hamuryudan V, Demir M, Hizli N, Sayman H, Melikoglu M, et al. Intestinal permeability in Behcet\u2019s syndrome. Ann Rheum Dis 60:65-6, 2001.","journal-title":"Ann Rheum Dis"},{"key":"9118_CR16","first-page":"128","volume":"26","author":"JH Vaile","year":"1999","unstructured":"Vaile JH, Meddings JB, Yacyshyn BR, Russell AS, Maksymowych WP. Bowel permeability and CD45RO expression on circulating CD20+ B cells in patients with ankylosing spondylitis and their relatives. J Rheumatol 26:128-35, 1999.","journal-title":"J Rheumatol"},{"key":"9118_CR17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1749-6632.2009.04037.x","volume":"1165","author":"J Visser","year":"2009","unstructured":"Visser J, Rozing J, Sapone A, Lammers K, Fasano A. Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann N Y Acad Sci 1165:195-205, 2009.","journal-title":"Ann N Y Acad Sci"},{"key":"9118_CR18","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1007\/s00125-006-0465-3","volume":"49","author":"E Bosi","year":"2006","unstructured":"Bosi E, Molteni L, Radaelli MG, Folini L, Fermo I, Bazzigaluppi E, et al. Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia 49:2824-7, 2006.","journal-title":"Diabetologia"},{"key":"9118_CR19","doi-asserted-by":"crossref","unstructured":"The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-97, 1997.","DOI":"10.2337\/diacare.20.7.1183"},{"key":"9118_CR20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0399-8320(07)89413-9","volume":"31","author":"A Manka\u00ef","year":"2007","unstructured":"Manka\u00ef A, Ben Hamouda H, Amri F, Ghedira-Besbes L, Harbi A, Tahar Sfar M, et al. Screening by anti-endomysium antibodies for celiac disease in Tunisian children with type 1 diabetes mellitus. Gastroenterol Clin Biol 31:462-466, 2007","journal-title":"Gastroenterol Clin Biol"},{"key":"9118_CR21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.patbio.2004.07.022","volume":"53","author":"A Manka\u00ef","year":"2005","unstructured":"Manka\u00ef A, Sakly W, Landolsi H, Gueddah L, Sriha B, Ayadi A, et al. Tissue transglutaminase antibodies in celiac disease, comparison of an enzyme linked immunosorbent assay and a dot blot assay. Pathol Biol 53:204-9, 2005.","journal-title":"Pathol Biol"},{"key":"9118_CR22","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S0140-6736(00)02169-3","volume":"355","author":"A Fasano","year":"2000","unstructured":"Fasano A, Not T, Wang W. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in celiac disease. Lancet 355:1518-9, 2000.","journal-title":"Lancet"},{"key":"9118_CR23","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1515\/JPEM.2007.20.12.1257","volume":"20","author":"A Franzese","year":"2007","unstructured":"Franzese A, Lombardi F, Valerio G, Spagnuolo MI. Update on coeliac disease and type 1 diabetes mellitus in childhood. J Pediatr Endocrinol Metab 20:1257-64, 2007.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"9118_CR24","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2337\/db05-1593","volume":"55","author":"A Sapone","year":"2006","unstructured":"Sapone A, de Magistris L, Pietzak M, Clemente MG, Tripathi A, Cucca F, et al. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes 55:1443-9, 2006.","journal-title":"Diabetes"},{"key":"9118_CR25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/0891693021000008526","volume":"35","author":"M Kuitunen","year":"2002","unstructured":"Kuitunen M, Saukkonen T, Ilonen J, Akerblom HK, Savilahti E. Intestinal permeability to mannitol and lactulose in children with type 1 diabetes with the HLA-DQB1*02 allele. Autoimmunity 35:365-58, 2002.","journal-title":"Autoimmunity"},{"key":"9118_CR26","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1530\/eje.0.1450757","volume":"145","author":"P Pozzilli","year":"2001","unstructured":"Pozzilli P, Mesturino CA, Crino A, Gross TM, Jeng LM, Visalli N; IMDIAB Group. Is the process of beta-cell destruction in type 1 diabetes at time of diagnosis more extensive in females than in males? Eur J Endocrinol 145:757-61, 2001.","journal-title":"Eur J Endocrinol"},{"key":"9118_CR27","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.2337\/diabetes.52.9.2287","volume":"52","author":"M Westerholm-Ormio","year":"2003","unstructured":"Westerholm-Ormio M, Vaarala O, Pihkala P, Ilonen J, Savilahti E. Immunologic activity in the small intestinal mucosa of pediatric patients with type 1 diabetes. Diabetes 52:2287-95, 2003.","journal-title":"Diabetes"},{"key":"9118_CR28","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.2337\/diabetes.53.7.1680","volume":"53","author":"R Auricchio","year":"2004","unstructured":"Auricchio R, Paparo F, Maglio M, Franzese A, Lombardi F, Valerio G, et al. In vitro-deranged intestinal immune response to gliadin in type 1 diabetes. Diabetes 53:1680-3, 2004.","journal-title":"Diabetes"},{"key":"9118_CR29","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.mehy.2007.05.058","volume":"70","author":"G Frisk","year":"2008","unstructured":"Frisk G, Hansson T, Dahlbom I, Tuvemo T. A unifying hypothesis on the development of type 1 diabetes and celiac disease: Gluten consumption may be a shared causative factor. Med Hypotheses 70:1207-9, 2008.","journal-title":"Med Hypotheses"},{"key":"9118_CR30","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.2337\/db08-0331","volume":"57","author":"O Vaarala","year":"2008","unstructured":"Vaarala O, Atkinson MA, Neu J. The \"perfect storm\" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 57:2555-62, 2008.","journal-title":"Diabetes"},{"key":"9118_CR31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.patbio.2005.02.005","volume":"54","author":"A Manka\u00ef","year":"2006","unstructured":"Manka\u00ef A, Landolsi H, Chahed A, Gueddah L, Limem M, Ben Abdessalem M, et al. Celiac disease in Tunisia: serological screening in healthy blood donors. Pathol Biol 54:10-3, 2006.","journal-title":"Pathol Biol"},{"key":"9118_CR32","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1056\/NEJMoa0807917","volume":"359","author":"DJ Smyth","year":"2008","unstructured":"Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JH, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 359:2767-77, 2008.","journal-title":"N Engl J Med"},{"key":"9118_CR33","doi-asserted-by":"crossref","first-page":"17729","DOI":"10.1073\/pnas.0509006102","volume":"102","author":"SJ Turley","year":"2005","unstructured":"Turley SJ, Lee JW, Dutton-Swain N, Mathis D, Benoist C. Endocrine self and gut non-self intersect in the pancreatic lymph nodes. Proc Natl Acad Sci USA 102:17729-33, 2005.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9118_CR34","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1210\/jc.2002-021177","volume":"88","author":"MR Pastore","year":"2003","unstructured":"Pastore MR, Bazzigaluppi E, Belloni C, Arcovio C, Bonifacio E, Bosi E. Six months of gluten-free diet do not influence autoantibody titers, but improve insulin secretion in subjects at high risk for type 1 diabetes. J Clin Endocrinol Metab 88:162-5, 2003.","journal-title":"J Clin Endocrinol Metab"},{"key":"9118_CR35","doi-asserted-by":"crossref","unstructured":"Standaert-Vitse A, Jouault T, Vandewalle P, Mille C, Seddik M, Sendid B, et al. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn\u2019s disease. Gastroenterology130:1764-75, 2006.","DOI":"10.1053\/j.gastro.2006.02.009"},{"key":"9118_CR36","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1099\/0022-1317-49-3-291","volume":"49","author":"AM Willis","year":"2000","unstructured":"Willis AM, Coulter WA, Hayes JR, Bell P, Lamey PJ. Factors affecting the adhesion of Candida albicans to epithelial cells of insulin-using diabetes mellitus patients. J Med Microbiol 49:291-3, 2000.","journal-title":"J Med Microbiol"},{"key":"9118_CR37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.diabres.2007.10.030","volume":"79","author":"H Sano","year":"2008","unstructured":"Sano H, Terasaki J, Tsutsumi C, Imagawa A, Hanafusa T. A case of fulminant type 1 diabetes mellitus after influenza B infection. Diabetes Res Clin Pract 79:8-9, 2008.","journal-title":"Diabetes Res Clin Pract"},{"key":"9118_CR38","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jaad.2005.03.057","volume":"54","author":"CC Chiou","year":"2006","unstructured":"Chiou CC, Chung WH, Hung SI, Yang LC, Hong HS. Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infection. J Am Acad Dermatol 54:S14-7, 2006.","journal-title":"J Am Acad Dermatol"},{"key":"9118_CR39","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1073\/pnas.0700442104","volume":"104","author":"F Dotta","year":"2007","unstructured":"Dotta F, Censini S, van Halteren AG, Marselli L, Masini M, Dionisi S, et al. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci USA 104:5115-20, 2007.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-010-9118-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12022-010-9118-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-010-9118-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:01:03Z","timestamp":1559440863000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12022-010-9118-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,13]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["9118"],"URL":"https:\/\/doi.org\/10.1007\/s12022-010-9118-7","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,13]]}}}